Erythropoietin Reduces Post-PCI Arrhythmias in Patients With ST-elevation Myocardial Infarction

BACKGROUND: Arrhythmia is the foremost cause of sudden death after myocardial infarction (MI). Animal models have recently shown that erythropoietin (EPO) can reduce the incidence of arrhythmia after MI. METHODS: We investigated the effects of administrating 33,000 IU EPO on the occurrence of post-M...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Cardiovasc Pharmacol
Main Authors: Gholamzadeh, Ali, Amini, Sara, Mohammadpour, Amir H., Vahabzadeh, Maryam, Fazelifar, Amir F., Fazlinezhad, Afsoon, Dehghani, Mashalla, Moohebati, Mohsen, Dastani, Mostafa, Malaekeh-Nikouie, Bizhan, Falsoleiman, Homa
Formato: Artigo
Idioma:Inglês
Publicado em: Journal of Cardiovascular Pharmacology 2015
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4461390/
https://ncbi.nlm.nih.gov/pubmed/25636071
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FJC.0000000000000223
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados